Enzalutamide promotes an early plasticity-associated transcriptional state without terminal neuroendocrine differentiation in prostate cancer cells.
Authors: Watanabe R, Chosei M, Arai H, Miura N, Kikugawa T, Saika T
Journal: Frontiers in oncology
acceptance commitment therapy
mental health
open access